A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer
Authors
Keywords
-
Journal
ONCOGENE
Volume 36, Issue 37, Pages 5285-5295
Publisher
Springer Nature
Online
2017-05-15
DOI
10.1038/onc.2017.153
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells
- (2016) Atsushi Umemura et al. CANCER CELL
- The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update
- (2016) Meng-Chen Lu et al. MEDICINAL RESEARCH REVIEWS
- New dimension of glucocorticoids in cancer treatment
- (2016) Kai-Ti Lin et al. STEROIDS
- The Dual Roles of NRF2 in Cancer
- (2016) Silvia Menegon et al. TRENDS IN MOLECULAR MEDICINE
- Cardiac glycosides display selective efficacy for STK11 mutant lung cancer
- (2016) Nayoung Kim et al. Scientific Reports
- Dysregulation of the Keap1–Nrf2 pathway in cancer: Figure 1
- (2015) Hanna M. Leinonen et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Epigenetic regulation of Keap1-Nrf2 signaling
- (2015) Yue Guo et al. FREE RADICAL BIOLOGY AND MEDICINE
- Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity—implications for therapeutic targeting of Nrf2
- (2015) Adedamola Olayanju et al. FREE RADICAL BIOLOGY AND MEDICINE
- Structural and functional characterization of Nrf2 degradation by glycogen synthase kinase 3/β-TrCP
- (2015) Antonio Cuadrado FREE RADICAL BIOLOGY AND MEDICINE
- Molecular basis of the Keap1–Nrf2 system
- (2015) Takafumi Suzuki et al. FREE RADICAL BIOLOGY AND MEDICINE
- Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds
- (2015) Nora Sundahl et al. PHARMACOLOGY & THERAPEUTICS
- Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities
- (2015) F. Skoulidis et al. Cancer Discovery
- Oncogenic KRAS Confers Chemoresistance by Upregulating NRF2
- (2014) S. Tao et al. CANCER RESEARCH
- LKB1 Loss Induces Characteristic Patterns of Gene Expression in Human Tumors Associated with NRF2 Activation and Attenuation of PI3K-AKT
- (2014) Jacob M. Kaufman et al. Journal of Thoracic Oncology
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1
- (2014) B. Faubert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evaluating the Cancer Therapeutic Potential of Cardiac Glycosides
- (2014) José Manuel Calderón-Montaño et al. Biomed Research International
- Cancer-Derived Mutations in KEAP1 Impair NRF2 Degradation but not Ubiquitination
- (2013) B. E. Hast et al. CANCER RESEARCH
- Antioxidant and Nrf2 inducing activities of luteolin, a flavonoid constituent in Ixeris sonchifolia Hance, provide neuroprotective effects against ischemia-induced cellular injury
- (2013) Yao-Chun Zhang et al. FOOD AND CHEMICAL TOXICOLOGY
- The emerging role of the Nrf2-Keap1 signaling pathway in cancer
- (2013) M. C. Jaramillo et al. GENES & DEVELOPMENT
- Cardiac glycosides in cancer therapy: from preclinical investigations towards clinical trials
- (2013) M. Slingerland et al. INVESTIGATIONAL NEW DRUGS
- Modulation of oxidative stress as an anticancer strategy
- (2013) Chiara Gorrini et al. NATURE REVIEWS DRUG DISCOVERY
- The in vivo antitumor activity of cardiac glycosides in mice xenografted with human cancer cells is probably an experimental artifact
- (2013) J M Calderón-Montaño et al. ONCOGENE
- Glucocorticoid receptor signaling in health and disease
- (2013) Mahita Kadmiel et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress
- (2012) Sang-Min Jeon et al. NATURE
- Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity
- (2012) A Arlt et al. ONCOGENE
- Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity
- (2012) S Chowdhry et al. ONCOGENE
- Suppression of the Nrf2-Dependent Antioxidant Response by Glucocorticoids and 11β-HSD1-Mediated Glucocorticoid Activation in Hepatic Cells
- (2012) Denise V. Kratschmar et al. PLoS One
- Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs
- (2011) Xiuwen Tang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells
- (2011) Yoshihiro Inami et al. JOURNAL OF CELL BIOLOGY
- SCF/ -TrCP Promotes Glycogen Synthase Kinase 3-Dependent Degradation of the Nrf2 Transcription Factor in a Keap1-Independent Manner
- (2011) P. Rada et al. MOLECULAR AND CELLULAR BIOLOGY
- Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
- (2011) Gina M. DeNicola et al. NATURE
- Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
- (2011) D. Ren et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prevention and treatment of systemic glucocorticoid side effects
- (2010) Siamak Moghadam-Kia et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Glycogen Synthase Kinase-3 Plays a Central Role in Mediating Glucocorticoid-Induced Apoptosis
- (2010) Rachel Spokoini et al. MOLECULAR ENDOCRINOLOGY
- β-TrCP Inhibition Reduces Prostate Cancer Cell Growth via Upregulation of the Aryl Hydrocarbon Receptor
- (2010) Udi Gluschnaider et al. PLoS One
- LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling
- (2010) Y. Gao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- LKB1 and AMP-activated protein kinase control of mTOR signalling and growth
- (2009) R. J. Shaw Acta Physiologica
- DNA Binding Site Sequence Directs Glucocorticoid Receptor Structure and Activity
- (2009) S. H. Meijsing et al. SCIENCE
- NRF2 as a determinant of cellular resistance in retinoic acid cytotoxicity
- (2008) Kah Poh Tan et al. FREE RADICAL BIOLOGY AND MEDICINE
- Cell lysis with dimethyl sulphoxide produces stable homogeneous solutions in the dichlorofluorescein oxidative stress assay
- (2008) Guqi Wang et al. FREE RADICAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started